• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床药代动力学:治疗药物监测与处方的综合系统。

Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing.

作者信息

Whiting B, Kelman A W, Bryson S M, Derkx F H, Thomson A H, Fotheringham G H, Joel S E

出版信息

Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):541-5. doi: 10.1136/bmj.288.6416.541.

DOI:10.1136/bmj.288.6416.541
PMID:6421372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1444562/
Abstract

Clinical pharmacokinetics is an expanding scientific discipline which can make an impact on treatment in coronary care, intensive care, paediatrics, general medicine and surgery, and general practice. The aim of this study was to establish a rapid system of drug assay, to report the result, to assess the influence of pathological and clinical factors on the pharmacokinetics of certain drugs, and to use a computer to determine the optimum dosage of drugs. The clinical pharmacokinetics laboratory in Stobhill is available to all clinical departments and to general practitioners in the area. Digoxin, theophylline, and phenytoin have been assessed. Initial samples of these drugs showed that only about a third were in the therapeutic range; samples obtained after the issue of the laboratory report showed an improvement. The predictive performance of the computer program improved with feedback of one or two drug concentrations. Dosages of drugs chosen on an empirical basis may not lead to optimum treatment, and by testing samples early the dosage of the drug can be adjusted. It is hoped that the results achieved will encourage other clinical, pharmaceutical, and scientific colleagues to develop laboratories along similar lines.

摘要

临床药代动力学是一门不断发展的科学学科,它能对冠心病护理、重症监护、儿科、普通内科和外科以及全科医疗中的治疗产生影响。本研究的目的是建立一个快速的药物检测系统,报告结果,评估病理和临床因素对某些药物药代动力学的影响,并使用计算机确定药物的最佳剂量。斯托布希尔的临床药代动力学实验室可供该地区所有临床科室和全科医生使用。已对地高辛、茶碱和苯妥英进行了评估。这些药物的初始样本显示只有约三分之一处于治疗范围内;在实验室报告发布后获取的样本显示情况有所改善。计算机程序的预测性能随着一两个药物浓度的反馈而提高。凭经验选择的药物剂量可能无法带来最佳治疗效果,通过早期检测样本可以调整药物剂量。希望所取得的结果将鼓励其他临床、药学和科研同事沿着类似的思路建立实验室。

相似文献

1
Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing.临床药代动力学:治疗药物监测与处方的综合系统。
Br Med J (Clin Res Ed). 1984 Feb 18;288(6416):541-5. doi: 10.1136/bmj.288.6416.541.
2
Clinical pharmacokinetics: the pharmacological monitoring of plasmatic levels in therapy.
Int J Clin Pharmacol Ther Toxicol. 1980;18(2):73-87.
3
Therapeutic drug monitoring: a survey of sub- and supra-therapeutic serum drug levels in a large teaching hospital.治疗药物监测:一家大型教学医院亚治疗和超治疗血清药物水平的调查
N Z Med J. 1982 Nov 10;95(719):774-6.
4
Computerized drug therapy: application of the hand-held microcomputer to dosage regimen design.
Int J Biomed Comput. 1985 Jul;17(1):49-55. doi: 10.1016/0020-7101(85)90072-8.
5
Comparison of drug dosing methods.药物给药方法的比较。
Clin Pharmacokinet. 1985 Jan-Feb;10(1):1-37. doi: 10.2165/00003088-198510010-00001.
6
Plasma concentrations of drugs as a guide to therapy in clinical practice.
Ir Med J. 1978 Nov 30;71(17):578-82.
7
Therapeutic drug monitoring in childhood.儿童治疗药物监测
Aust Paediatr J. 1986 Feb;22(1):19-26. doi: 10.1111/j.1440-1754.1986.tb00177.x.
8
Drug interferences with plasma assays in therapeutic drug monitoring.治疗药物监测中药物对血浆分析的干扰。
Clin Pharmacokinet. 1984 Jan-Feb;9(1):67-87. doi: 10.2165/00003088-198409010-00004.
9
Use of serum drug concentrations in surgical patients.血清药物浓度在外科患者中的应用。
Am J Surg. 1988 Jul;156(1):68-76. doi: 10.1016/s0002-9610(88)80176-4.
10
Effect of pharmacist intervention on the use of serum drug assays.药剂师干预对血清药物检测使用情况的影响。
Am J Hosp Pharm. 1981 Jun;38(6):845-51.

引用本文的文献

1
Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.急性心房颤动患者静脉注射地高辛:基于急性心房颤动地高辛试验的群体药代动力学/药效学分析
Eur J Clin Pharmacol. 2003 Mar;58(11):747-55. doi: 10.1007/s00228-002-0553-3. Epub 2003 Feb 19.
2
Pharmacogenetics: the therapeutic drug monitoring of the future?药物遗传学:未来的治疗药物监测?
Clin Pharmacokinet. 2001;40(11):783-802. doi: 10.2165/00003088-200140110-00001.
3
Clinical pharmacy in primary care.基层医疗中的临床药学
Br J Clin Pharmacol. 1998 Nov;46(5):415-20. doi: 10.1046/j.1365-2125.1998.00818.x.
4
Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?
Clin Pharmacokinet. 1998 Apr;34(4):265-79. doi: 10.2165/00003088-199834040-00001.
5
Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin.临床药代动力学中用于参数优化的微机程序(OPT)评估:庆大霉素和妥布霉素
Br J Clin Pharmacol. 1987 Oct;24(4):511-8. doi: 10.1111/j.1365-2125.1987.tb03205.x.
6
The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.使用每日一次给药的茶碱药代动力学预测指标的准确性。
Br J Clin Pharmacol. 1987 Sep;24(3):301-7. doi: 10.1111/j.1365-2125.1987.tb03173.x.
7
Cost-effectiveness of therapeutic drug monitoring.治疗药物监测的成本效益
Clin Pharmacokinet. 1987 Sep;13(3):131-40. doi: 10.2165/00003088-198713030-00001.
8
The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.治疗药物监测对执业医师的价值——一个有待检验的假设。
Br J Clin Pharmacol. 1989 Mar;27(3):281-4. doi: 10.1111/j.1365-2125.1989.tb05365.x.
9
Therapeutic drug monitoring of antiarrhythmic drugs. Rationale and current status.抗心律失常药物的治疗药物监测。基本原理与现状。
Clin Pharmacokinet. 1990 Feb;18(2):91-103. doi: 10.2165/00003088-199018020-00001.
10
Bayesian parameter estimation and population pharmacokinetics.
Clin Pharmacokinet. 1992 Jun;22(6):447-67. doi: 10.2165/00003088-199222060-00004.

本文引用的文献

1
Some suggestions for measuring predictive performance.一些关于衡量预测性能的建议。
J Pharmacokinet Biopharm. 1981 Aug;9(4):503-12. doi: 10.1007/BF01060893.
2
Predicting individual phenytoin dosage.
J Pharmacokinet Biopharm. 1981 Apr;9(2):131-46. doi: 10.1007/BF01068078.
3
Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods.药代动力学的贝叶斯个体化:简单实现及与非贝叶斯方法的比较。
J Pharm Sci. 1982 Dec;71(12):1344-8. doi: 10.1002/jps.2600711209.
4
OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics.OPT:一套用于临床药代动力学参数优化的计算机程序。
Br J Clin Pharmacol. 1982 Aug;14(2):247-56. doi: 10.1111/j.1365-2125.1982.tb01969.x.
5
Individualization of phenytoin dosage regimens.
Clin Pharmacol Ther. 1977 Mar;21(3):287-93. doi: 10.1002/cpt1977213287.
6
Optimal phenytoin therapy: a new technique for individualizing dosage.
Clin Pharmacol Ther. 1978 Feb;23(2):228-32. doi: 10.1002/cpt1978232228.
7
Predicting phenytoin dose - a revised nomogram.预测苯妥英钠剂量——一种修订的列线图。
Ther Drug Monit. 1979;1(3):325-33. doi: 10.1097/00007691-197901030-00007.
8
Forecasting individual pharmacokinetics.预测个体药代动力学。
Clin Pharmacol Ther. 1979 Sep;26(3):294-305. doi: 10.1002/cpt1979263294.
9
Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.影响茶碱清除率的因素:年龄、烟草、大麻、肝硬化、充血性心力衰竭、肥胖、口服避孕药、苯二氮䓬类药物、巴比妥类药物和乙醇。
J Pharm Sci. 1979 Nov;68(11):1358-66. doi: 10.1002/jps.2600681106.